• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Mandated risk-benefit counseling decreases rate of vaccine exemptions

byStephanie Harlow, MDandCordelia Ross
December 18, 2017
in Infectious Disease, Pediatrics, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In Washington State, legislation requiring physicians to counsel patients seeking vaccine exemption led to significant decrease in patients actually obtaining exemptions.

2. Legislature-mandated counseling also led to a decrease in the geographic clustering of vaccine-exempt children.

Evidence Rating Level: 2 (Good)      

Study Rundown: In the United States, patients may pursue vaccine exemption based on the regulations of their individual state, some allowing exemption for medical or religions reasons, and some for reasons of personal belief. In recent years, the state of Washington changed its exemption laws, requiring parents seeking exemptions for their children entering kindergarten to discuss with their healthcare providers the risks and benefits of immunization and to sign a form confirming they had completed this discussion. After the implementation of this law, data from the State Department revealed a significant decrease in the number of patients receiving exemptions as well as a relative decrease in the rate of exemptions. There was also a decrease in the likelihood that kindergartners without exemptions would encounter those with exemptions. Additionally, the likelihood that kindergartners with exemptions would interact with other such kindergartners also decreased. Finally, there was a notable decrease in the expected exemption rates, particularly in geographic areas with an anticipated high-density of vaccine exemption. Though vaccine counseling adds time to an already short well-child visit, this study clearly demonstrates its benefit in decreasing the rate of vaccine exemptions, particularly in a traditionally vaccine-hesitate state.

Click here to read the original article, published today in Pediatrics

Relevant Reading: Effective Messages in Vaccine Promotion: A Randomized Trial

In-Depth [retrospective cohort]: Researchers gathered data about kindergartener vaccination and exemption rates from the Washington State Department of Health from school year 1997-1998 to school year 2013-2014. The law requiring healthcare provider counseling on vaccine risks and benefits, known as Senate Bill 5005 (SB5005), was implemented in July 22, 2011. Researched used linear fit models to assess for the absolute changes in vaccination and exemption rates after the law’s implementation. Interaction and aggregation indices were used to calculate the likelihood of exposure of children with exemptions to children without exemptions as well as to other children with exemptions. After the implementation of SB5005, there was a 40.2% (95% Confidence Interval [CI]: -42.6% to -36.6%) decrease in the rates of exemption in Washington State. This decrease translated to an absolute reduction of vaccine exemption of 2.9% (95% CI: -4.2% to -1.7%). There was a general decrease in the likelihood that a kindergartener with an exemption would encounter other such kindergarteners. Furthermore, regions in the northern part of the state, where high rates of exemption are generally concentrated, saw a decrease in exemptions in many regions after the law’s implementation.

RELATED REPORTS

Human papillomavirus (HPV) vaccination rates have increased in recent years

Human papillomavirus vaccine effective in preventing infections in the United States

Inactivated, adjuvant enterovirus 71 vaccine is safe and effective against fatal enterovirus infections in children aged 2-71 months

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: vaccinationvaccine refusal
Previous Post

Ablation of refractory ventricular tachycardia with a novel, noninvasive radiation technique

Next Post

Household prescription opioid exposure linked to small increased risk of opioid initiation

RelatedReports

Mental health parity law associated with financial protection for children
Chronic Disease

Human papillomavirus (HPV) vaccination rates have increased in recent years

June 23, 2022
Reduced doses of human papillomavirus vaccine may be effective in preventing condyloma
Public Health

Human papillomavirus vaccine effective in preventing infections in the United States

June 23, 2022
Preterm infants responsive to PCV13 vaccine
Infectious Disease

Inactivated, adjuvant enterovirus 71 vaccine is safe and effective against fatal enterovirus infections in children aged 2-71 months

May 10, 2022
Medical vaccine exemptions increase after elimination of nonmedical exemptions
Chronic Disease

Vaccination leads to a small absolute risk for shoulder conditions

April 22, 2022
Next Post
Ultrasound enhances gastrointestinal absorption of drugs at low frequencies

Household prescription opioid exposure linked to small increased risk of opioid initiation

High-intensity treadmill exercise may slow progression of motor symptoms in early Parkinson’s disease

High-intensity treadmill exercise may slow progression of motor symptoms in early Parkinson’s disease

Home scoring system may prevent unnecessary pharyngitis clinic visits

2 Minute Medicine Rewind December 18, 2017

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Sickle cell trait associated with preexisting kidney comorbidities and increased COVID-19 mortality
  • Adding atezolizumab to standard of care treatment for human epidermal growth factor receptor 2 (HER2) positive early breast cancer does not improve pathologic response outcomes
  • FOLFOX combined with nivolumab and trastuzumab in ERBB2-positive esophagogastric adenocarcinoma is an emerging therapy option
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.